Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market
GLP-1 drugs are reshaping healthcare and consumer markets. These ETFs offer targeted exposure to the booming obesity-drug trend.
Zacks
More News
NYSE Content Advisory: Pre-Market Update + AAF Advertising Hall of Fame to Ring NYSE Closing Bell
NYSE Content Advisory: Pre-Market Update + AAF Advertising Hall of Fame to Ring NYSE Closing Bell NYSE Content Advisory: Pre-Market Update + AAF Advertising Hall of Fame to Ring NYSE Closing Bell PR...
PR Newswire
Eli Lilly Hits $1 Trillion Milestone: ETFs to Invest in
Lilly's $1T valuation and soaring GLP-1 demand spotlight ETFs like IHE, PPH, MEDI, OZEM, MEDX and THNR for investors riding the weight-loss drug boom.
Zacks
Time to Buy UnitedHealth-Heavy ETFs?
Berkshire's $1.57B stake in UnitedHealth lifted shares by 12%, sparking interest in UNH-heavy healthcare ETFs like IHF, TMED, XLV and MEDI.
Zacks
Invest Like Warren Buffett With These ETFs
Buffett's Berkshire reshapes its portfolio with big bets on UnitedHealth and housing, while trimming Apple and Bank of America. The big bets put focus on ETFs like IHF and ITB.
Zacks
ETFs in Focus on Eli Lilly's Solid Q2 Earnings, Weak Obesity Data
LLY tumbles despite solid Q2 results. ETFs like IHE, PPH, MEDX and MEDI with top exposure may offer buy-the-dip opportunities.